BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Vedolizumab
1
Dual biologic therapy in patient with refractory ulcerative colitis and comorbidities: A case report
12/19/2025 10:39:41 AM | Browse: 58 | Download: 227
2
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study
12/18/2024 7:36:01 AM | Browse: 133 | Download: 619
3
Refractory ulcerative colitis: Upadacitinib versus other biologics
9/11/2024 6:37:28 AM | Browse: 147 | Download: 497
4
Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report
3/25/2024 8:14:32 AM | Browse: 172 | Download: 816
5
Pediatric-type follicular lymphoma in a Crohn’s disease patient receiving anti-α4β7-integrin therapy: A case report
11/20/2023 6:17:21 AM | Browse: 263 | Download: 904
6
Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors
4/25/2023 11:32:55 PM | Browse: 254 | Download: 806
7
Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
9/29/2022 9:17:29 AM | Browse: 590 | Download: 1456
8
Vedolizumab-associated diffuse interstitial lung disease in patients with ulcerative colitis: A case report
2/11/2022 5:55:20 AM | Browse: 683 | Download: 1964
9
Differential diagnosis and management of immune checkpoint inhibitor-induced colitis: A comprehensive review
12/29/2021 9:44:51 AM | Browse: 664 | Download: 1311
10
Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review
3/3/2021 10:02:01 AM | Browse: 852 | Download: 2332
11
Vedolizumab in Crohn’s disease with rectal fistulas and presacral abscess: A case report
1/29/2021 7:57:41 AM | Browse: 655 | Download: 1625
12
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus
11/20/2020 4:04:17 AM | Browse: 1051 | Download: 2514
13
Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford
8/14/2020 12:33:31 PM | Browse: 1101 | Download: 2177
14
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
10/25/2019 8:06:40 AM | Browse: 909 | Download: 1745
15
Effectiveness of vedolizumab treatment in two different anti-tumor necrosis factor alpha refractory pouchitis: A case report
8/26/2019 2:56:47 AM | Browse: 812 | Download: 1963
16
Vedolizumab for inflammatory bowel disease: from randomized controlled trials to real-life evidence
6/15/2018 9:13:16 AM | Browse: 1494 | Download: 2377
17
Anti-integrin therapy for inflammatory bowel disease
5/6/2018 1:12:00 PM | Browse: 1216 | Download: 1627
18
Combination therapy for inflammatory bowel disease
5/4/2017 8:16:34 AM | Browse: 1405 | Download: 2143
19
Review of vedolizumab for the treatment of ulcerative colitis
1/29/2016 11:06:00 AM | Browse: 1350 | Download: 1520
20
Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
5/30/2015 1:35:00 PM | Browse: 1359 | Download: 1912
21
When combination therapy isn’t working: Emerging therapies for the management of inflammatory bowel disease
9/3/2014 2:27:00 PM | Browse: 1119 | Download: 1519